
Opthea Limited OPT
Opthea Limited ROCE Ratio | OPT
Annual ROCE Ratio Opthea Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77.47 | -153.8 | 2563.22 | -201.1 | - | - | - | -78.27 | -18.14 | -53.75 | -43.0 | -71.09 | -56.25 | -44.94 | -54.06 |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2563.22 | -201.1 | 155.52 |
Quarterly ROCE Ratio Opthea Limited
| 2025-Q4 | 2025-Q2 | 2024-Q4 | 2024-Q2 | 2023-Q4 | 2023-Q2 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2486.88 | 77.47 | - | -153.8 | - | 2563.22 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2563.22 | -153.8 | 1243.44 |
ROCE Ratio of other stocks in the Biotechnology industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | ||
|
bluebird bio
BLUE
|
-194.9 | - | - | $ 546 M | ||
|
Landos Biopharma
LABP
|
-71.49 | - | 0.58 % | $ 144 M | ||
|
CASI Pharmaceuticals
CASI
|
-59.84 | - | - | $ 35.4 M | ||
|
ContraFect Corporation
CFRX
|
545.12 | - | -5.16 % | $ 5.39 M | ||
|
Sigilon Therapeutics
SGTX
|
-111.56 | - | - | $ 728 M | ||
|
Regulus Therapeutics
RGLS
|
-65.26 | - | - | $ 155 M | ||
|
NGM Biopharmaceuticals
NGM
|
-101.9 | - | - | $ 127 M | ||
|
Aravive
ARAV
|
-664.7 | - | -13.39 % | $ 1.45 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-88.5 | - | - | $ 231 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
-52.09 | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
Acer Therapeutics
ACER
|
146.85 | - | 2.71 % | $ 14 M | ||
|
Gilead Sciences
GILD
|
44.14 | $ 166.01 | -0.31 % | $ 207 B | ||
|
Assembly Biosciences
ASMB
|
-5.8 | $ 22.14 | -1.6 % | $ 248 M | ||
|
Dynavax Technologies Corporation
DVAX
|
-0.69 | - | - | $ 2.02 B | ||
|
Turning Point Therapeutics
TPTX
|
-24.94 | - | -0.13 % | $ 3.73 B | ||
|
Orgenesis
ORGS
|
155.73 | - | -33.86 % | $ 61.2 M | ||
|
TCR2 Therapeutics
TCRR
|
-108.97 | - | - | $ 58.1 M | ||
|
ASLAN Pharmaceuticals Limited
ASLN
|
-379.93 | - | -14.27 % | $ 1.7 M | ||
|
Adverum Biotechnologies
ADVM
|
-196.79 | - | - | $ 86.2 M | ||
|
BELLUS Health
BLU
|
-19.87 | - | - | $ 2.47 B | ||
|
Intra-Cellular Therapies
ITCI
|
-10.16 | - | - | $ 13.6 B | ||
|
Marinus Pharmaceuticals
MRNS
|
-784.28 | - | - | $ 29.6 M | ||
|
GeoVax Labs
GOVX
|
-230.13 | $ 1.83 | -4.45 % | $ 8.35 M | ||
|
Unity Biotechnology
UBX
|
-480.0 | - | -33.41 % | $ 3.37 M | ||
|
Applied Molecular Transport
AMTI
|
-209.11 | - | - | $ 10.1 M | ||
|
Tyme Technologies
TYME
|
-31.64 | - | 8.07 % | $ 54 M | ||
|
Karuna Therapeutics
KRTX
|
-39.02 | - | - | $ 12.2 B | ||
|
Corner Growth Acquisition Corp.
COOL
|
669.98 | - | -0.89 % | $ 114 M | ||
|
Revance Therapeutics
RVNC
|
-81.39 | - | - | $ 309 M | ||
|
Aptinyx
APTX
|
-163.42 | - | -39.0 % | $ 4.57 M | ||
|
TRACON Pharmaceuticals
TCON
|
1146.23 | - | -1.38 % | $ 46.8 M | ||
|
Forward Pharma A/S
FWP
|
-5.47 | - | -0.75 % | $ 18.7 M | ||
|
9 Meters Biopharma
NMTR
|
-1750.31 | - | -42.97 % | $ 1.05 M | ||
|
Theratechnologies
THTX
|
49.6 | - | - | $ 83.9 M | ||
|
Allena Pharmaceuticals
ALNA
|
-53.64 | - | 3.16 % | $ 1.9 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-37.9 | - | -15.15 % | $ 60.3 M | ||
|
TFF Pharmaceuticals
TFFP
|
-228.86 | - | -60.05 % | $ 125 K | ||
|
Codiak BioSciences
CDAK
|
-48.13 | - | -55.98 % | $ 2.15 M | ||
|
Sage Therapeutics
SAGE
|
-90.91 | - | - | $ 527 M | ||
|
Paratek Pharmaceuticals
PRTK
|
27.02 | - | - | $ 121 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-7.11 | - | - | $ 521 M | ||
|
Cyclerion Therapeutics
CYCN
|
-47.25 | $ 34.99 | 3.77 % | $ 147 M | ||
|
Seelos Therapeutics
SEEL
|
120.86 | - | -47.76 % | $ 6.27 M | ||
|
Завод ДИОД
DIOD
|
5.84 | - | - | - | ||
|
Kiromic BioPharma
KRBP
|
192.36 | - | 6.61 % | $ 3.08 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
-60.12 | - | - | $ 2.18 B | ||
|
Fusion Pharmaceuticals
FUSN
|
-44.6 | - | - | $ 1.41 B | ||
|
Gritstone Oncology
GRTS
|
-269.28 | - | 0.42 % | $ 213 M | ||
|
Aridis Pharmaceuticals
ARDS
|
123.77 | - | 17.91 % | $ 11.1 M |